Affymax, Inc. Logo

Email this page: News Release

Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis


Separate multiple addresses with commas. Maximum 200 characters.

These email addresses will be used to email the page on your behalf and will not be used by Affymax, Inc. for any marketing purposes.


This helps Affymax, Inc. prevent automated submissions.